The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II trial of PTK787/ZK 222584 (PTK787) in recurrent high-grade meningioma.
S. A. Grimm
No relevant relationships to disclose
M. C. Chamberlain
No relevant relationships to disclose
J. Chandler
No relevant relationships to disclose
K. Muro
No relevant relationships to disclose
L. Rice
No relevant relationships to disclose
K. McCarthy
No relevant relationships to disclose
A. Rademaker
No relevant relationships to disclose
I. B. Helenowski
No relevant relationships to disclose
S. K. Johnston
No relevant relationships to disclose
M. M. Mrugala
No relevant relationships to disclose
J. J. Raizer
No relevant relationships to disclose